- Sort by Sort ascending
- Job Title Sort ascending
- Site
- Location
- Division
- Business
- Functional Area
- Date Posted
Job Title Sort ascending | Site | Location | Division | Business | Functional Area | Date Posted |
---|---|---|---|---|---|---|
Senior Manager - Compliance and Risk Operations | Hyderabad (Office) | India | Operations | CTS | Legal & Intellectual Property & Compl. | Jul 16, 2024 |
Specialist | Hyderabad (Office) | India | Operations | CTS | Legal & Intellectual Property & Compl. | Jul 09, 2024 |
Manager, Center of Excellence | Head Office (Japan) (Pharmaceuticals) | Japan | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jul 07, 2024 |
Head DPDAI China | Shanghai (Shanghai) | China | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jul 04, 2024 |
Patent Paralegal | Cambridge (USA) | USA | Legal | Pharma Research | Legal & Intellectual Property & Compl. | Jul 03, 2024 |
Senior Legal Counsel | Shanghai (Shanghai) | China | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | Jul 02, 2024 |
Manager - Compliance Analytics and Reporting | Hyderabad (Office) | India | Operations | CTS | Legal & Intellectual Property & Compl. | Jul 02, 2024 |
Ethics Risk & Compliance Sr. Manager Mexico International | INSURGENTES | Mexico | Ethics Risk & Compliance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jun 27, 2024 |
Manager, Managed Markets Finance Compliance | East Hanover (New Jersey) | USA | Finance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jun 25, 2024 |
Manager, Data & Digital Compliance | East Hanover (New Jersey) | USA | Finance | Innovative Medicines | Legal & Intellectual Property & Compl. | Jun 25, 2024 |
Senior Manager ERC Monitoring and Remediation | Selangor | Malaysia | Ethics Risk & Compliance | Corporate | Legal & Intellectual Property & Compl. | Jun 19, 2024 |
Associate Director, Global Security Investigator | Mapletree Business City (MBC) | Singapore | Corporate | Corporate | Legal & Intellectual Property & Compl. | Jun 03, 2024 |
US Paralegal Site Head | Cambridge (USA) | USA | Legal | Pharma Research | Legal & Intellectual Property & Compl. | May 23, 2024 |
Senior Legal Counsel, Operations China | Shanghai (Shanghai) | China | Legal | Innovative Medicines | Legal & Intellectual Property & Compl. | May 06, 2024 |
Associate Director, Global Security Investigator | East Hanover | USA | Legal | Corporate | Legal & Intellectual Property & Compl. | Apr 10, 2024 |
To report an adverse event or any drug related issues concerning Novartis medicinal products; please contact Novartis Patient Safety: Tel: +202 22861000 - Press 3 for reporting an adverse event.
E-mail: [email protected]
للإبلاغ عن أثر جانبى أو أي مشكلة دوائية متعلقة بمنتجات نوفارتس الطبية او الاجهزة ؛ يرجى الاتصال بقسم اليقظة الدوائية في شركة نوفارتس
+202 22861000 : الهاتف
ثم اضغط 3 للإبلاغ عن أثر جانبي +
[email protected] البريد الإلكترونى